More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Rates of drug overdose deaths decreased in the U.S. for the first time since the pandemic began, according to new federal data published Thursday.

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...